BIOMAT Database Logo BIOMAT Database Logo

Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. 1998

R G Rosenfeld, and K M Attie, and J Frane, and J A Brasel, and S Burstein, and J F Cara, and S Chernausek, and R W Gotlin, and J Kuntze, and B M Lippe, and C P Mahoney, and W V Moore, and P Saenger, and A J Johanson
Department of Pediatrics, Oregon Health Sciences University, Portland 97201, USA.

OBJECTIVE To carry out a multicenter, prospective, randomized trial of human growth hormone (GH), alone or in combination with oxandrolone (OX), in patients with Turner's syndrome (TS). METHODS In an initial phase lasting 12 to 24 months, 70 girls with TS, verified by karyotype, were randomly assigned to one of four groups: (1) observation, (2) OX, (3) GH, or (4) GH plus OX. After completion of the first phase, group 3 subjects continued to receive GH only. All other subjects were treated with GH plus OX. Subjects were followed up until attainment of adult height and/or cessation of treatment. Data from this trial were compared with growth characteristics of 25 American historical subjects with TS (matched for age, height, parental target height, and karyotype) who never received either GH or androgens. RESULTS Of the 70 subjects enrolled, 60 completed the clinical trial. The 17 subjects receiving GH alone all completed the trial and reached a height of 150.4+/-5.5 cm (mean +/- SD), 8.4+/-4.5 cm taller than their mean projected adult height at enrollment (95% confidence interval [CI]: 6.3 to 10.6 cm). The 43 subjects receiving GH plus OX attained a mean height of 152.1+/-5.9 cm, 10.3+/-4.7 cm taller than their mean projected adult height (95% CI: 8.9 to 11.7 cm). The historical control subjects had a mean adult height of 144.2+/-6.0 cm, precisely matching their original projected adult height of 144.2+/-6.1 cm. CONCLUSIONS GH, either alone or in combination with OX, is capable of stimulating short-term growth and augmenting adult height in girls with TS. With early diagnosis and initiation of treatment, an adult height of more than 150 cm is a reasonable goal for most girls with TS.

UI MeSH Term Description Entries
D010074 Oxandrolone A synthetic hormone with anabolic and androgenic properties. Anavar,Oxandrin,SC-11585,SC 11585,SC11585
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001827 Body Height The distance from the sole to the crown of the head with body standing on a flat surface and fully extended. Body Heights,Height, Body,Heights, Body
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D014424 Turner Syndrome A syndrome of defective gonadal development in phenotypic females associated with the karyotype 45,X (or 45,XO). Patients generally are of short stature with undifferentiated GONADS (streak gonads), SEXUAL INFANTILISM, HYPOGONADISM, webbing of the neck, cubitus valgus, elevated GONADOTROPINS, decreased ESTRADIOL level in blood, and CONGENITAL HEART DEFECTS. NOONAN SYNDROME (also called Pseudo-Turner Syndrome and Male Turner Syndrome) resembles this disorder; however, it occurs in males and females with a normal karyotype and is inherited as an autosomal dominant. Bonnevie-Ullrich Syndrome,Gonadal Dysgenesis, 45,X,Gonadal Dysgenesis, XO,Monosomy X,Status Bonnevie-Ullrich,Turner's Syndrome,Ullrich-Turner Syndrome,Bonnevie Ullrich Syndrome,Status Bonnevie Ullrich,Syndrome, Ullrich-Turner,Turners Syndrome,Ullrich Turner Syndrome,XO Gonadal Dysgenesis

Related Publications

R G Rosenfeld, and K M Attie, and J Frane, and J A Brasel, and S Burstein, and J F Cara, and S Chernausek, and R W Gotlin, and J Kuntze, and B M Lippe, and C P Mahoney, and W V Moore, and P Saenger, and A J Johanson
Does growth-hormone supplementation affect adult height in Turner's syndrome?
July 1996, Lancet (London, England),
R G Rosenfeld, and K M Attie, and J Frane, and J A Brasel, and S Burstein, and J F Cara, and S Chernausek, and R W Gotlin, and J Kuntze, and B M Lippe, and C P Mahoney, and W V Moore, and P Saenger, and A J Johanson
[Growth hormone therapy in Turner's syndrome: analysis of the effect of therapy on the final height].
January 1994, Problemy endokrinologii,
R G Rosenfeld, and K M Attie, and J Frane, and J A Brasel, and S Burstein, and J F Cara, and S Chernausek, and R W Gotlin, and J Kuntze, and B M Lippe, and C P Mahoney, and W V Moore, and P Saenger, and A J Johanson
Variable effect of growth hormone on growth and final adult height in Scottish patients with Turner's syndrome.
February 1997, Acta paediatrica (Oslo, Norway : 1992),
R G Rosenfeld, and K M Attie, and J Frane, and J A Brasel, and S Burstein, and J F Cara, and S Chernausek, and R W Gotlin, and J Kuntze, and B M Lippe, and C P Mahoney, and W V Moore, and P Saenger, and A J Johanson
Growth hormone therapy and final height in girls with Turner's syndrome.
December 1991, Acta paediatrica Scandinavica,
R G Rosenfeld, and K M Attie, and J Frane, and J A Brasel, and S Burstein, and J F Cara, and S Chernausek, and R W Gotlin, and J Kuntze, and B M Lippe, and C P Mahoney, and W V Moore, and P Saenger, and A J Johanson
Effect of growth hormone therapy on adult height of children with Turner syndrome.
September 2008, Journal of the Formosan Medical Association = Taiwan yi zhi,
R G Rosenfeld, and K M Attie, and J Frane, and J A Brasel, and S Burstein, and J F Cara, and S Chernausek, and R W Gotlin, and J Kuntze, and B M Lippe, and C P Mahoney, and W V Moore, and P Saenger, and A J Johanson
Growth hormone therapy in Turner's syndrome.
June 1992, Irish medical journal,
R G Rosenfeld, and K M Attie, and J Frane, and J A Brasel, and S Burstein, and J F Cara, and S Chernausek, and R W Gotlin, and J Kuntze, and B M Lippe, and C P Mahoney, and W V Moore, and P Saenger, and A J Johanson
Update on growth hormone therapy for Turner's syndrome.
January 1989, Acta paediatrica Scandinavica. Supplement,
R G Rosenfeld, and K M Attie, and J Frane, and J A Brasel, and S Burstein, and J F Cara, and S Chernausek, and R W Gotlin, and J Kuntze, and B M Lippe, and C P Mahoney, and W V Moore, and P Saenger, and A J Johanson
Effect of oxandrolone on growth and final height in Turner's syndrome.
January 1990, Acta paediatrica Scandinavica,
R G Rosenfeld, and K M Attie, and J Frane, and J A Brasel, and S Burstein, and J F Cara, and S Chernausek, and R W Gotlin, and J Kuntze, and B M Lippe, and C P Mahoney, and W V Moore, and P Saenger, and A J Johanson
Factors attenuating growth promoting effect of growth hormone therapy for Turner's syndrome.
October 1988, Endocrinologia japonica,
R G Rosenfeld, and K M Attie, and J Frane, and J A Brasel, and S Burstein, and J F Cara, and S Chernausek, and R W Gotlin, and J Kuntze, and B M Lippe, and C P Mahoney, and W V Moore, and P Saenger, and A J Johanson
Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
September 1992, Acta paediatrica (Oslo, Norway : 1992). Supplement,
Copied contents to your clipboard!